Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 29.02
+0.44 (1.54%)
At close: Mar 27, 2026
Giant Biogene Holding Revenue
In the year 2025, Giant Biogene Holding had annual revenue of 5.52B CNY, down -0.37%. Giant Biogene Holding had revenue of 2.41B in the half year ending December 31, 2025, with 25.41% growth.
Revenue
5.52B CNY
Revenue Growth
-0.37%
P/S Ratio
5.02
Revenue / Employee
2.55M CNY
Employees
2,162
Market Cap
30.81B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.52B | -20.30M | -0.37% |
| Dec 31, 2024 | 5.54B | 2.01B | 57.17% |
| Dec 31, 2023 | 3.52B | 1.16B | 49.05% |
| Dec 31, 2022 | 2.36B | 811.96M | 52.30% |
| Dec 31, 2021 | 1.55B | 362.01M | 30.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hengan International Group Company | 25.67B |
| Blue Moon Group Holdings | 8.46B |
| Shanghai Chicmax Cosmetic | 8.11B |
| Mao Geping Cosmetics | 4.93B |
| Shanghai Forest Cabin Cosmetics Group | 2.73B |
| Eternal Beauty Holdings | 2.24B |
| Cheerwin Group | 2.21B |
| Butong Group | 1.53B |
Giant Biogene Holding News
- 10 months ago - Giant Biogene Bruised In A 'Battle Of The Skincare Belles' - Benzinga